참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 1,2-Dichloroethane | HCID 11 | — |
| 반응물 | Trifluoroacetic acid | HCID 6422 | — |
| 반응물 | 4-Methylmorpholine | HCID 7972 | — |
| 반응물 | HOAt | HCID 181649 | — |
| 반응물 | 6-cyclopropyl-1-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | HCID 2525992 | — |
| 반응물 | 3-(aminomethyl)-4-isopropyl-6-methylpyridin-2(1H)-one | HCID 67124337 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | HCID 56597560 | HCID 56597560 | — |
반응 단계
The title compound was prepared in the same manner as described in example 7 from 6-cyclopropyl-1-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (250 mg, 1.019 mmol), 3-(aminomethyl)-6-methyl-4-(1-methylethyl)-2(1H)-pyridinone.TFA (300 mg, 1.019 mmol), HOAT (208 mg, 1.529 mmol), EDC (293 mg, 1.529 mmol), N-methylmorpholine (0.448 mL, 4.08 mmol), and DMF (6 mL), wherein the reaction time was 48 h. The final product was collected following a basic extraction (to remove residual starting material) as a white solid, 30 mg (7%). LCMS E-S (M+H)=408.3. 1H NMR (400 MHz, DMSO-d6) δ ppm 0.95-1.16 (m, 10H), 1.38-1.54 (m, 6H), 2.16 (s 3H), 2.19-2.30 (m, 1H), 3.12-3.29 (m, 1H), 4.29-4.48 (m, 2H), 5.03-5.21 (m, 1H), 6.03 (s, 1H), 7.39 (s, 1H), 8.21 (s, 1H), 8.63-8.81 (m, 1H), 11.56 (s, 1H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08637509B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_01 |
|---|
| ORD ID | ord-0305a7130ba7429a81964ddb48af7e6c |
|---|
| 출처 메모 | uspto-grants-2014_01 |
|---|